Hepatocellular benign tumors-from molecular classification to personalized clinical care

Gastroenterology

Volumn 144, Issue 5, 2013, Pages 888-902

  Nault, Jean Charles ^a,b   Bioulac Sage, Paulette ^a,c   Zucman Rossi, Jessica ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL PELLEGRIN   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

CTNNB1; GNAS; gp130; STAT3

Indexed keywords

ALCOHOL; APC PROTEIN; BETA CATENIN; C REACTIVE PROTEIN; CYTOCHROME P450 1B1; FATTY ACID BINDING PROTEIN; GLUTAMATE AMMONIA LIGASE; GLYCOGEN SYNTHASE KINASE 3BETA; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; LIVER FATTY ACID BINDING PROTEIN; ORAL CONTRACEPTIVE AGENT; SERUM AMYLOID A; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ALCOHOL CONSUMPTION; CANCER CLASSIFICATION; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; GENE OVEREXPRESSION; HEPATOCELLULAR ADENOMA; HISTOPATHOLOGY; HUMAN; LIVER ADENOMA; LIVER CELL; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; MOLECULAR GENETICS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ONCOGENE; ORAL CONTRACEPTION; PATHOPHYSIOLOGY; PATIENT CARE; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 84876494014     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.02.032     Document Type: Review

References (150)

1. O. Shaked, E.S. Siegelman, K. Olthoff Biologic and clinical features of benign solid and cystic lesions of the liver Clin Gastroenterol Hepatol 9 2011 547 562 e1-4
2. L. Gandolfi, P. Leo, L. Solmi Natural history of hepatic haemangiomas: clinical and ultrasound study Gut 32 1991 677 680
3. S. Rebouissou, P. Bioulac-Sage, J. Zucman-Rossi Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma J Hepatol 48 2008 163 170
4. I.R. Wanless Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules Hepatology 11 1990 787 797
5. P.J. Karhunen Benign hepatic tumours and tumour like conditions in men J Clin Pathol 39 1986 183 188
6. R.G. Gibney, A.P. Hendin, P.L. Cooperberg Sonographically detected hepatic hemangiomas: absence of change over time AJR Am J Roentgenol 149 1987 953 957
7. D. Mathieu, H. Kobeiter, D. Cherqui Oral contraceptive intake in women with focal nodular hyperplasia of the liver Lancet 352 1998 1679 1680
8. D. Mathieu, H. Kobeiter, P. Maison Oral contraceptive use and focal nodular hyperplasia of the liver Gastroenterology 118 2000 560 564
9. J.B. Rooks, H.W. Ory, K.G. Ishak Epidemiology of hepatocellular adenoma The role of oral contraceptive use JAMA 242 1979 644 648
10. L.A. Heinemann, A. Weimann, G. Gerken Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study Eur J Contracept Reprod Health Care 3 1998 194 200
11. M. Sasaki, Y. Nakanuma Overview of hepatocellular adenoma in Japan Int J Hepatol 2012 2012 648131
12. Y. Matsumoto, S. Yamabe, T. Sugishima Perception of oral contraceptives among women of reproductive age in Japan: a comparison with the USA and France J Obstet Gynaecol Res 37 2011 887 892
13. P. Bioulac-Sage, S. Rebouissou, A. Sa Cunha Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver Gastroenterology 128 2005 1211 1218
14. V. Paradis, A. Champault, M. Ronot Telangiectatic adenoma: an entity associated with increased body mass index and inflammation Hepatology 46 2007 140 146
15. J. Zucman-Rossi, E. Jeannot, J.T. Nhieu Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC Hepatology 43 2006 515 524
16. C. Bunchorntavakul, R. Bahirwani, D. Drazek Clinical features and natural history of hepatocellular adenomas: the impact of obesity Aliment Pharmacol Ther 34 2011 664 674
17. P. Bioulac-Sage, J.F. Blanc, S. Rebouissou Genotype phenotype classification of hepatocellular adenoma World J Gastroenterol 13 2007 2649 2654
18. P. Bioulac-Sage, S. Rebouissou, C. Thomas Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry Hepatology 46 2007 740 748
19. S. Rebouissou, G. Couchy, L. Libbrecht The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules J Hepatol 49 2008 61 71
20. V. Paradis, A. Benzekri, D. Dargere Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma Gastroenterology 126 2004 1323 1329
21. S.M. van Aalten, C.D. Witjes, R.A. de Man Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int 32 2012 28 37
22. P. Bioulac-Sage, H. Laumonier, G. Couchy Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience Hepatology 50 2009 481 489
23. B.N. Nguyen, J.F. Flejou, B. Terris Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms Am J Surg Pathol 23 1999 1441 1454
24. I.R. Wanless, C. Mawdsley, R. Adams On the pathogenesis of focal nodular hyperplasia of the liver Hepatology 5 1985 1194 1200
25. Y. Fukukura, O. Nakashima, A. Kusaba Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver J Hepatol 29 1998 470 475
26. M.J. Gaffey, J.C. Iezzoni, L.M. Weiss Clonal analysis of focal nodular hyperplasia of the liver Am J Pathol 148 1996 1089 1096
27. V. Paradis, A. Laurent, J.F. Flejou Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation Hepatology 26 1997 891 895
28. Y.J. Chen, P.J. Chen, M.C. Lee Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization Genes Chromosomes Cancer 35 2002 138 143
29. Y.R. Cai, L. Gong, X.Y. Teng Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma World J Gastroenterol 15 2009 4695 4708
30. J.Y. Scoazec, J.F. Flejou, A. D'Errico Focal nodular hyperplasia of the liver: composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules Hum Pathol 26 1995 1114 1125
31. V. Paradis, I. Bieche, D. Dargere A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia Gastroenterology 124 2003 651 659
32. S. Benhamouche, T. Decaens, C. Godard Apc tumor suppressor gene is the "zonation-keeper" of mouse liver Dev Cell 10 2006 759 770
33. P. Bioulac-Sage, H. Laumonier, A. Rullier Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology Liver Int 29 2009 459 465
34. D. Cherqui, A. Rahmouni, F. Charlotte Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations Hepatology 22 1995 1674 1681
35. V. Vilgrain, F. Uzan, G. Brancatelli Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis Radiology 229 2003 75 79
36. G. Brancatelli, M.P. Federle, L. Grazioli Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients Radiology 219 2001 61 68
37. C. Laurent, H. Trillaud, S. Lepreux Association of adenoma and focal nodular hyperplasia: experience of a single French academic center Comp Hepatol 2 2003 6
38. C. Ibarrola, V.M. Castellano, F. Colina Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules Histopathology 44 2004 172 179
39. T.M. Chandler, M.K. Heran, S.D. Chang Multiple focal nodular hyperplasia lesions of the liver associated with congenital absence of the portal vein Magn Reson Imaging 29 2011 881 886
40. E. Buscarini, C. Danesino, H. Plauchu High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia Ultrasound Med Biol 30 2004 1089 1097
41. K.J. Mortele, M. Praet, H. Van Vlierberghe CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation AJR Am J Roentgenol 175 2000 687 692
42. V. Vilgrain, J.F. Flejou, L. Arrive Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients Radiology 184 1992 699 703
43. A. Fabre, P. Audet, V. Vilgrain Histologic scoring of liver biopsy in focal nodular hyperplasia with atypical presentation Hepatology 35 2002 414 420
44. S. Dardenne, C. Hubert, C. Sempoux Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm Eur J Gastroenterol Hepatol 22 2010 1337 1344
45. A. Perrakis, R. Demir, V. Muller Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only Am J Surg 204 2012 689 696
46. P. Bioulac-Sage, G. Cubel, C. Balabaud Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers Semin Liver Dis 31 2011 91 103
47. J.F. Flejou, J. Barge, Y. Menu Liver adenomatosis An entity distinct from liver adenoma? Gastroenterology 89 1985 1132 1138
48. L. Chiche, T. Dao, E. Salame Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature Ann Surg 231 2000 74 81
49. M. Sasaki, N. Yoneda, S. Kitamura Characterization of hepatocellular adenoma based on the phenotypic classification: the Kanazawa experience Hepatol Res 41 2011 982 988
50. M. Ronot, S. Bahrami, J. Calderaro Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification Hepatology 53 2011 1182 1191
51. S.M. van Aalten, J. Verheij, T. Terkivatan Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice J Hepatol 55 2011 120 125
52. S. Dokmak, V. Paradis, V. Vilgrain A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas Gastroenterology 137 2009 1698 1705
53. C.O. Bellamy, R.S. Maxwell, S. Prost The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre Histopathology 62 2013 431 445
54. S. Van der Borght, L. Libbrecht, A. Katoonizadeh Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy Histopathology 51 2007 855 856
55. K.J. Evason, J.P. Grenert, L.D. Ferrell Atypical hepatocellular adenoma-like neoplasms with beta-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas Hum Pathol 2012 Oct 16 [Epub ahead of print]
56. O. Bluteau, E. Jeannot, P. Bioulac-Sage Bi-allelic inactivation of TCF1 in hepatic adenomas Nat Genet 32 2002 312 315
57. K. Yamagata, N. Oda, P.J. Kaisaki Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature 384 1996 455 458
58. A.G. Knudson Jr Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci U S A 68 1971 820 823
59. Y. Bacq, E. Jacquemin, C. Balabaud Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation Gastroenterology 125 2003 1470 1475
60. E. Jeannot, G. Lacape, H. Gin Double heterozygous germline HNF1A mutations in a patient with liver adenomatosis Diabetes Care 35 2012 e35
61. Y. Reznik, T. Dao, R. Coutant Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families J Clin Endocrinol Metab 89 2004 1476 1480
62. A.M. Lerario, L.P. Brito, B.M. Mariani A missense TCF1 mutation in a patient with mody-3 and liver adenomatosis Clinics (Sao Paulo) 65 2010 1059 1060
63. M. Pontoglio, J. Barra, M. Hadchouel Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome Cell 84 1996 575 585
64. Y.H. Lee, B. Sauer, F.J. Gonzalez Laron dwarfism and non-insulin- dependent diabetes mellitus in the Hnf-1alpha knockout mouse Mol Cell Biol 18 1998 3059 3068
65. A.D. Tward, K.D. Jones, S. Yant Distinct pathways of genomic progression to benign and malignant tumors of the liver Proc Natl Acad Sci U S A 104 2007 14771 14776
66. T.E. Akiyama, J.M. Ward, F.J. Gonzalez Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha) Alterations in fatty acid homeostasis in HNF1alpha-deficient mice J Biol Chem 275 2000 27117 27122
67. D.Q. Shih, M. Bussen, E. Sehayek Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism Nat Genet 27 2001 375 382
68. D.T. Odom, N. Zizlsperger, D.B. Gordon Control of pancreas and liver gene expression by HNF transcription factors Science 303 2004 1378 1381
69. S. Rebouissou, S. Imbeaud, C. Balabaud HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation J Biol Chem 282 2007 14437 14446
70. L. Pelletier, S. Rebouissou, A. Paris Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis Hepatology 51 2010 557 566
71. L. Pelletier, S. Rebouissou, D. Vignjevic HNF1alpha inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines BMC Cancer 11 2011 427
72. X. Zeng, Y. Lin, C. Yin Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice Hepatology 54 2011 2036 2047
73. Y.W. Chen, Y.M. Jeng, S.H. Yeh P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia Hepatology 36 2002 927 935
74. H. Clevers, R. Nusse Wnt/beta-catenin signaling and disease Cell 149 2012 1192 1205
75. A. Cadoret, C. Ovejero, B. Terris New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism Oncogene 21 2002 8293 8301
76. A. Micsenyi, X. Tan, T. Sneddon Beta-catenin is temporally regulated during normal liver development Gastroenterology 126 2004 1134 1146
77. S. Colnot, T. Decaens, M. Niwa-Kawakita Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas Proc Natl Acad Sci U S A 101 2004 17216 17221
78. J.C. Nault, J. Zucman-Rossi Genetics of hepatobiliary carcinogenesis Semin Liver Dis 31 2011 173 187
79. A. Cadoret, C. Ovejero, S. Saadi-Kheddouci Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin Cancer Res 61 2001 3245 3249
80. N. Harada, H. Miyoshi, N. Murai Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin Cancer Res 62 2002 1971 1977
81. N. Harada, H. Oshima, M. Katoh Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations Cancer Res 64 2004 48 54
82. V. Audard, G. Grimber, C. Elie Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations J Pathol 212 2007 345 352
83. O. Farges, N. Ferreira, S. Dokmak Changing trends in malignant transformation of hepatocellular adenoma Gut 60 2011 85 89
84. S. Rebouissou, M. Amessou, G. Couchy Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours Nature 457 2009 200 204
85. C. Guichard, G. Amaddeo, S. Imbeaud Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Nat Genet 44 2012 694 698
86. C. Pilati, M. Amessou, M.P. Bihl Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas J Exp Med 208 2011 1359 1366
87. J.C. Nault, M. Fabre, G. Couchy GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation J Hepatol 56 2012 184 191
88. S.I. Grivennikov, F.R. Greten, M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
89. J. Sommer, T. Effenberger, E. Volpi Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling J Biol Chem 287 2012 13743 13751
90. L.S. Weinstein, J. Liu, A. Sakamoto Minireview: GNAS: normal and abnormal functions Endocrinology 145 2004 5459 5464
91. C.K. Ong, C. Subimerb, C. Pairojkul Exome sequencing of liver fluke-associated cholangiocarcinoma Nat Genet 44 2012 690 693
92. L.S. Weinstein, A. Shenker, P.V. Gejman Activating mutations of the stimulatory G protein in the McCune-Albright syndrome N Engl J Med 325 1991 1688 1695
93. A. Shenker, L.S. Weinstein, A. Moran Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS J Pediatr 123 1993 509 518
94. A. Sa Cunha, J.F. Blanc, E. Lazaro Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management Gut 56 2007 307 309
95. D.A. Weinstein, C.N. Roy, M.D. Fleming Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease Blood 100 2002 3776 3781
96. L.M. Judd, B.M. Alderman, M. Howlett Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130 Gastroenterology 126 2004 196 207
97. J.H. Foster, T.A. Donohue, M.M. Berman Familial liver-cell adenomas and diabetes mellitus N Engl J Med 299 1978 239 241
98. J. Watkins, C. Balabaud, P. Bioulac-Sage Hepatocellular adenoma in advanced-stage fatty liver disease Eur J Gastroenterol Hepatol 21 2009 932 936
99. P. Labrune, P. Trioche, I. Duvaltier Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature J Pediatr Gastroenterol Nutr 24 1997 276 279
100. P.S. Kishnani, T.P. Chuang, D. Bali Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease Hum Mol Genet 18 2009 4781 4790
101. S.K. Reddy, P.S. Kishnani, J.A. Sullivan Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia J Hepatol 47 2007 658 663
102. E. Mutel, A. Abdul-Wahed, N. Ramamonjisoa Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas J Hepatol 54 2011 529 537
103. D. Cassiman, L. Libbrecht, C. Verslype An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia J Hepatol 53 2010 213 217
104. Y.M. Lee, H.S. Jun, C.J. Pan Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy Hepatology 56 2012 1719 1729
105. J. Calderaro, P. Labrune, G. Morcrette Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I J Hepatol 58 2013 350 357
106. P. Bioulac-Sage, H. Laumonier, G. Cubel Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins Liver Int 30 2010 149 154
107. H. Laumonier, A. Rullier, J. Saric Unexpected discovery of 2 cases of hepatocyte nuclear factor 1alpha-mutated infracentimetic adenomatosis World J Gastroenterol 14 2008 4830 4833
108. S. Lepreux, C. Laurent, J.F. Blanc The identification of small nodules in liver adenomatosis J Hepatol 39 2003 77 85
109. J.B. Rooks, H.W. Ory, K.G. Ishak The association between oral contraception and hepatocellular adenoma - a preliminary report Int J Gynaecol Obstet 15 1977 143 144
110. H.A. Edmondson, B. Henderson, B. Benton Liver-cell adenomas associated with use of oral contraceptives N Engl J Med 294 1976 470 472
111. E. Jeannot, L. Mellottee, P. Bioulac-Sage Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage Diabetes 59 2010 1836 1844
112. M. Svrcek, E. Jeannot, L. Arrive Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis Eur J Endocrinol 156 2007 617 621
113. H. Buhler, M. Pirovino, A. Akobiantz Regression of liver cell adenoma A follow-up study of three consecutive patients after discontinuation of oral contraceptive use Gastroenterology 82 1982 775 782
114. W.M. Christopherson, E.T. Mays, G. Barrows A clinicopathologic study of steroid-related liver tumors Am J Surg Pathol 1 1977 31 41
115. L. Socas, M. Zumbado, O. Perez-Luzardo Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature Br J Sports Med 39 2005 e27
116. M. Torbenson, J.H. Lee, M. Choti Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway Mod Pathol 15 2002 189 196
117. C. Toso, L. Rubbia-Brandt, F. Negro Hepatocellular adenoma and polycystic ovary syndrome Liver Int 23 2003 35 37
118. U. Beuers, W.O. Richter, M.M. Ritter Klinefelter's syndrome and liver adenoma J Clin Gastroenterol 13 1991 214 216
119. D. Westaby, B. Portmann, R. Williams Androgen related primary hepatic tumors in non-Fanconi patients Cancer 51 1983 1947 1952
120. C. Cerminara, V. Bagnolo, F. De Leonardis Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report Childs Nerv Syst 28 2012 939 941
121. K. Tazawa, M. Yasuda, Y. Ohtani Multiple hepatocellular adenomas associated with long-term carbamazepine Histopathology 35 1999 92 94
122. E. Jeannot, K. Poussin, L. Chiche Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma Cancer Res 67 2007 2611 2616
123. P. Bioulac-Sage, S. Taouji, L. Possenti Hepatocellular adenoma subtypes: the impact of overweight and obesity Liver Int 32 2012 1217 1221
124. Y.S. Chun, J. Calderaro, J. Zucman-Rossi Synchronous hepatocellular carcinoma and Castleman's disease: the role of the interleukin-6-signaling pathway Hepatology 56 2012 392 393
125. J. Han, M.C. van den Heuvel, H. Kusano How normal is the liver in which the inflammatory type hepatocellular adenoma develops? Int J Hepatol 2012 2012 805621
126. P. Bioulac-Sage, G. Cubel, S. Taouji Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes Am J Surg Pathol 36 2012 1691 1699
127. H. Laumonier, P. Bioulac-Sage, C. Laurent Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification Hepatology 48 2008 808 818
128. S.M. van Aalten, M.G. Thomeer, T. Terkivatan Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification Radiology 261 2011 172 181
129. A.F. Manichon, B. Bancel, M. Durieux-Millon Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions HPB Surg 2012 2012 418745
130. M. Bieze, J.W. van den Esschert, C.Y. Nio Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium AJR Am J Roentgenol 199 2012 26 34
131. L. Grazioli, M.P. Bondioni, H. Haradome Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis Radiology 262 2012 520 529
132. A. Ba-Ssalamah, M. Uffmann, S. Saini Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions Eur Radiol 19 2009 342 357
133. J.L. Deneve, T.M. Pawlik, S. Cunningham Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy Ann Surg Oncol 16 2009 640 648
134. J.H. Stoot, R.J. Coelen, M.C. De Jong Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases HPB (Oxford) 12 2010 509 522
135. E.J. Gyorffy, J.E. Bredfeldt, W.C. Black Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use Ann Intern Med 110 1989 489 490
136. C.D. Witjes, F.J. Ten Kate, S.M. van Aalten Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against Gut 61 2012 1645 1646
137. S.W. Cho, J.W. Marsh, J. Steel Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 15 2008 2795 2803
138. D. Erdogan, O.R. Busch, O.M. van Delden Management of spontaneous haemorrhage and rupture of hepatocellular adenomas A single centre experience Liver Int 26 2006 433 438
139. K.P. Croome, M.H. Yamashita Laparoscopic vs open hepatic resection for benign and malignant tumors: an updated meta-analysis Arch Surg 145 2010 1109 1118
140. P. Herman, F.F. Coelho, M.V. Perini Hepatocellular adenoma: an excellent indication for laparoscopic liver resection HPB (Oxford) 14 2012 390 395
141. M.G. van Vledder, S.M. van Aalten, T. Terkivatan Safety and efficacy of radiofrequency ablation for hepatocellular adenoma J Vasc Interv Radiol 22 2011 787 793
142. J.P. Lerut, O. Ciccarelli, C. Sempoux Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation Transpl Int 16 2003 879 884
143. J.E. Noels, S.M. van Aalten, D.J. van der Windt Management of hepatocellular adenoma during pregnancy J Hepatol 54 2011 553 558
144. J.H. Stoot, J. van Roosmalen, O.T. Terpstra Life-threatening hemorrhage from adenomas in the liver during pregnancy Dig Surg 23 2006 155
145. S.M. van Aalten, R.A. de Man, J.N. IJzermans Systematic review of haemorrhage and rupture of hepatocellular adenomas Br J Surg 99 2012 911 916
146. J.H. Stoot, E. van der Linden, O.T. Terpstra Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization Br J Surg 94 2007 1249 1253
147. V.A. Huurman, A.F. Schaapherder Management of ruptured hepatocellular adenoma Dig Surg 27 2010 56 60
148. H.L. Koskela, S. Eldfors, P. Ellonen Somatic STAT3 mutations in large granular lymphocytic leukemia N Engl J Med 366 2012 1905 1913
149. S. Sakellariou, H. Al-Hussaini, A. Scalori Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study Histopathology 60 2012 E58 E65
150. Fonseca DH, Dardenne S, Annet L, et al. Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience. Int J Hepatol (in press).